[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370806-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370806-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-linc01315-encoded-small-protein-yaper-orf-competes-with-prp4k-to-hijack-yap-signaling-to-aberrantly-promote-cell-growth","The LINC01315-encoded small protein YAPer-ORF competes with PRP4k to hijack YAP signaling to aberrantly promote cell growth","","YAP activity dysregulation drives abnormal organ size and diverse diseases, yet how lncRNA-encoded peptides regulate YAP remains unclear. This study identifies YAPer-ORF, a 93 aa small protein encoded by LINC01315, which preferentially interacts with GNAQ/11 mutants to enhance YAP activity. In the nucleus, YAPer-ORF competes with YAP to bind PRP4K, reduces YAP phosphorylation, promotes nuclear retention, and elevates CCND1-dependent proliferation. Genetic knock-in increases heart size in mice, and anti-YAPer-ORF antibody suppresses uveal melanoma growth, supporting therapeutic targeting of YAPer-ORF.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-linc01315-encoded-small-protein-yaper-orf-competes-with-prp4k-to-hijack-yap-signaling-to-aberrantly-promote-cell-growth/370806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-linc01315-encoded-small-protein-yaper-orf-competes-with-prp4k-to-hijack-yap-signaling-to-aberrantly-promote-cell-growth/370806.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is YAPer-ORF and which lncRNA encodes it?","Question",{"text":63,"@type":64},"YAPer-ORF is a small protein (93 aa) encoded by the lncRNA LINC01315.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does YAPer-ORF mechanistically regulate YAP activity?",{"text":68,"@type":64},"YAPer-ORF localizes to the nucleus and competes with YAP to bind the kinase PRP4K, hindering YAP phosphorylation and promoting YAP nuclear retention and downstream gene expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports YAPer-ORF as a driver of cell proliferation and a therapeutic target?",{"text":72,"@type":64},"YAPer-ORF promotes CCND1-dependent proliferation in both cancerous and noncancerous models, increases heart size in mice via cardiomyocyte proliferation, and anti-YAPer-ORF neutralizing antibody suppresses uveal melanoma growth.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370806,1790364961,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cdd](www.nature.com/cdd)  \nARTICLE OPEN   \nThe LINC01315-encoded small protein YAPer-ORF competes with PRP4k to hijack YAP signaling to aberrantly promote cell growth  \nZhu Xie 1,9, Chao Li1,9, Rui Huang2,9, Bo Wu3, Qian Huang4, Zhe Zhang2, Tongjin Zhao 5, Lingqian Wu6, Chengtao Li7, Jianfeng Shen 2 ✉ and Hongyan Wang 1,8 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | The dysregulation of YAP activity is implicated in abnormal organ size and the pathogenesis of diverse diseases, including cancer. However, the functional regulation of YAP activity by lncRNA-encoded peptides remains elusive. In this study, we report the identiﬁcation of a small protein (93 aa) encoded by the lncRNA LINC01315 . This small protein, termed YAPer-ORF, preferentially interacted with GNAQ/11 mutants to augment YAP activity. Mechanistically, YAPer-ORF was located in the nucleus and competed with YAP to bind the nuclear kinase PRP4K to hinder YAP phosphorylation. This decreased phosphorylation of YAP by YAPer-ORF promoted YAP retention in the nucleus and facilitated the expression of downstream target genes such as CCND1 . In both cancerous and noncancerous models, YAPer-ORF prominently drove cell proliferation in a CCND1-dependent manner. Notably, cardiac-speciﬁc genetic knock-in of the human YAPer-ORF in mice signiﬁcantly increased heart size through increased cardiomyocyte proliferation, underscoring the role of YAPer-ORF in cell proliferation. Moreover, treatment with an anti-YAPer-ORF neutralizing antibody effectively suppressed uveal melanoma growth, highlighting the therapeutic potential of targeting YAPerORF. These ﬁndings collectively establish YAPer-ORF as a critical regulator of YAP activity, further highlighting the disruption of |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| YAPer-ORF activity as a potential therapeutic strategy against YAP-driven human cancers and developmental diseases. |  |  |\n|  | Cell Death & Differentiation (2025) 32:1428–1440; [https://doi.org/10.1038/s41418-025-01449-z](https://doi.org/10.1038/s41418-025-01449-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe Hippo-YAP pathway is an evolutionarily conserved signaling cascade that performs pivotal functions in diverse physiological and pathological processes [1]. As a transcriptional coactivator, YAP is central to the Hippo-YAP signaling pathway. Importantly, the dephosphorylation of YAP at serine 127 and 397 facilitates its translocation to the nucleus, where YAP interacts with TAZ/TEAD to activate the transcription of downstream target genes, thereby initiating developmental disorders and cancers [2, 3]. Consequently, strategies aimed at inhibiting YAP activity have emerged as potential therapeutic interventions, either by perturbing the YAP-TEAD interface or by targeting the core kinases in the pathway. However, existing approaches to inhibit YAP, such as verteporﬁn, have exhibited both systemic proteotoxic effects and cytotoxicity, thereby limiting their clinical viability [4]. Thus, there is an unmet need to develop therapeutic methods that are speciﬁcally tailored to counteract hyperactive YAP while preserving its normal physiological activity.  \nNoncoding RNAs, particularly long noncoding RNAs (lncRNAs), prominently contribute to the regulation of Hippo-YAP signaling  \nand its associated disorders [5, 6] . LncRNAs are autonomously transcribed RNA molecules over 200 nucleotides in length that do not encode protein products [7, 8] . Recent investigations have revealed the presence of small open reading frames (smORFs) within a subset of lncRNAs that have the potential to encode small peptides or proteins [9, 10] . Notably, smORF primary sequences exhibit greater conservation and higher expression levels than do introns and other lncRNA regions, suggesting that lncRNAs might perform more substantial biological functions than do previously recognized lncRNAs [11] ","cbCaijeZyc3D1Nan","https://ap.wps.com/l/cbCaijeZyc3D1Nan","pdf",5274155,13,"English","# Introduction\n## Hippo-YAP pathway and YAP activation\n## Therapeutic inhibition of YAP\n## lncRNAs and lncRNA-encoded small peptides","[{\"question\":\"What is YAPer-ORF and which lncRNA encodes it?\",\"answer\":\"YAPer-ORF is a small protein (93 aa) encoded by the lncRNA LINC01315.\"},{\"question\":\"How does YAPer-ORF mechanistically regulate YAP activity?\",\"answer\":\"YAPer-ORF localizes to the nucleus and competes with YAP to bind the kinase PRP4K, hindering YAP phosphorylation and promoting YAP nuclear retention and downstream gene expression.\"},{\"question\":\"What evidence supports YAPer-ORF as a driver of cell proliferation and a therapeutic target?\",\"answer\":\"YAPer-ORF promotes CCND1-dependent proliferation in both cancerous and noncancerous models, increases heart size in mice via cardiomyocyte proliferation, and anti-YAPer-ORF neutralizing antibody suppresses uveal melanoma growth.\"}]","The LINC01315-encoded small protein YAPer-ORF competes with PRP4k to hijack YAP signaling to aberrantly promote cell growth | PDF",1790190447,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99f0c28c005ac4b9338f8b410ce51662.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a1ee943ed94d684d49e18a22fda14a0.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bf8d0a51ff5f00f8a9999ec36572130.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30ba62242d5175a710a50723c7a00405.webp",980,1301]